Red: Someone on Yahoo suggested we might be able t
Post# of 30028
1) Analytical Validation. Gerald said we are doing this now during the option period, prior to exercising the option. (2 months?) This is what Beckton Dickenson did for Lympro back in the Fall of 2013.
2) Clinical Study. Gerald said Georgetown is doing this larger less homogenized study now! (3 months?) This is equivalent to LymPro's LP002 study.
3) Lab Validation. That is what ICON completed for Lympro in December. (3 months)
These tests can overlap, as our LP002 did with our ICON Lab Validation. So I figure we can get all this done in 5 months and, cross your fingers, have the complete suite ready for Research Use Only by July for the AAIC Meeting. CLIA would follow shortly thereafter.
This is how we're seeing the process now.
The fact that we brought on the lady doctor from Eli Lilly that was a Senior Medical Advisor for Amivid....tells me we are for real in all of this!!!!